Murali Doraiswamy is a doctor and translational scientist at Duke University where he directs a clinical trials unit developing novel technologies and treatments for enhancing brain health. He has served as an advisor to leading businesses, government agencies and patient advocacy groups.
Murali has been a health advisor for Men's Health magazine and AARP Magazine, and is a co-author of a popular book, The Alzheimer's Action Plan. His research has been featured in media outlets such as The New York Times, Oprah, Dr Oz Show, CBS Morning, Discovery, BBC, USA Today, NPR, and BBC.
Dr. Doraiswamy is a member of the World Economic Forum's Global Future Councils.
Education and Training
- M.B.B.S., University of Madras (India), 1987
- Genetic and Non-Genetic Modulators of Morbidity/Disability Compression in a Large Population-Based Study of Cognitive and Physical Impairment with Emphasis on Alzheimer's Disease and Related Dementias
- Racial and Geographic Disparities in Risk and Survival of Alzheimer's Disease and Related Dementias
- Duke Creating ADRD Researchers for the Next Generation - Stimulating Access to Research in Residency Program (CARiNG-StARR)"
- Metabolomic Signatures for Disease Sub-classification and Target Prioritization in AMP-AD
- Evaluating Effects in the Relationship between Traumatic Brain Injury and Alzheimer's Disease: Epidemiological Determinants, Their Health-Related Causes and the Resulting Disparities
- Gut Liver Brain Biochemical Axis in Alzheimer's Disease
- Metabolic Networks and Pathways Predictive of Sex Differences in AD Risk and Responsiveness to Treatment
- Predicting prebiotic effects on human microbiota, behavior, and cognition.
- Does rifaximin improve cognition in patients with Alzheimer's disease?" using Manufacturer's drug XIFAXAN
- Correspondence Between 18F-AV-1451 PET Imaging and Post-Mortem Assessment of Tau Pathology
- Phase 3 Clinical Trial for Agitation in Alzheimer's 15-AVP-786-301
- Phase 3 Clinical Trial for Agitation in Alzheimer's 15-AVP-786-303
- Effects of Traumatic Brain Injury (TBI) and Post Traumatic Stress Disorder (PTSD) on Alzheimer's Disease (AD) in Veterans Using Imaging and Biomarkers in the AD Neuroimaging Initiative (ADNI) (DoD)
- Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder on Alzheimer's Disease (AD) in Veterans with Mild Cognitive Impairment (MC) using the Alzheimer's disease neuroimaging initiative
- DoD-ADNI Tau
- Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)
- Metabolic Network Analysis of Biochemical Trajectories in Alzheimer's Disease
- High Resolution Intracortical DTI for Early Detection of Alzheimer¿s Disease
- Metabolic Signatures Underlying Vascular Risk Factors for Alzheimer-type Dementias